Final Results of Peginterferon Alfa-2b Add-on during Long-term Nucleos(t)ide Analogue Therapy in HBeAg-positive Patients - a Multicenter Randomized Controlled Trial (PEGON Study)

被引：0
作者：
Chi, Heng [1 ]
Xie, Qing [2 ]
Zhang, Ning-Ping [3 ]
Qi, Xun [4 ]
Liang, Chen [4 ]
Guo, Simin [2 ]
Guo, Qing [2 ]
Arends, Pauline [1 ]
Wang, Jiyao [3 ]
Verhey, Elke [1 ]
de Knegt, Robert J. [1 ]
Hansen, Bettina E. [1 ]
Janssen, Harry L. [1 ,5 ]
机构：
[1] Erasmus MC Univ Med Ctr Rotterdam, Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Infect Dis, Shanghai 200030, Peoples R China
[3] Fudan Univ, Dept Gastroenterol & Hepatol, Zhongshan Hosp, Shanghai 200433, Peoples R China
[4] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Hepatitis Dis, Shanghai 200433, Peoples R China
[5] Univ Toronto, Toronto Gen & Western Hosp, Toronto Ctr Liver Dis, Toronto, ON, Canada
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2002
引用
收藏
页码：1183A / 1183A
页数：1
相关论文
共 50 条
  • [31] Letter: safe and effective cessation of long-term nucleos(t)ide analogue therapy in noncirrhotic patients with HBeAg-negative chronic hepatitis B
    Hadziyannis, S. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (02) : 236 - 237
  • [32] Incidence and predictors of flares after discontinuing nucleos (t)ide analogue therapy in HBeAg negative patients with chronic hepatitis B: Results from the randomized controlled STOP study
    Liem, Seng
    Fung, Scott
    Wong, David
    Yim, Colina
    Chen, Jenny
    Noureldin, Seham
    Feld, Jordan
    Hansen, Bettina
    Janssen, Harry
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E474 - E474
  • [33] INCIDENCE FOR LOSS-TO-FOLLOW-UP IN PATIENTS WITH CHRONIC HEPATITIS B DURING LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY
    Su Chung-Wei
    Yen-Chun Liu
    Chien-Wei Peng
    Wen-Juei Jeng
    Rong-Nan Chien
    Yun-Fan Liaw
    HEPATOLOGY, 2022, 76 : S289 - S290
  • [34] HBSAG LOSS IS ENOUGH TO DISCONTINUE LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN REAL PRACTICE?
    Fasano, M.
    Ciarallo, M.
    Niro, G.
    Fontana, R.
    Cozzolongo, R.
    Maci, A.
    Carraturo, I.
    Miglietta, A.
    Angarano, G.
    Santantonio, T.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E12 - E12
  • [35] CHANGES OF SERUM HBSAG LEVELS IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS UNDER LONG-TERM THERAPY WITH NUCLEOS(T)IDE ANALOGUE(S)
    Papatheodordis, George V.
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Margariti, Ekaterini
    Exarchos, Xenofon
    Kokkonis, George
    Papaioannou, Christos
    Akriviasdis, Evangelos A.
    Manesis, Emanuel K.
    HEPATOLOGY, 2011, 54 : 1054A - 1054A
  • [36] HBSAG LOSS IS ENOUGH TO DISCONTINUE LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN REAL PRACTICE?
    Fasano, M.
    Ciarallo, M.
    Niro, G.
    Fontana, R.
    Cozzolongo, R.
    Maci, A.
    Carraturo, I.
    Miglietta, A.
    Angarano, G.
    Santantonio, T.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S370 - S371
  • [37] A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients
    Kayaaslan, Bircan
    Akinci, Esragul
    Ari, Alpay
    Tufan, Zeliha Kocak
    Alpat, Saygin Nayman
    Gunal, Ozgur
    Tosun, Selma
    Guner, Rahmet
    Tabak, Fehmi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2018, 42 (01) : 40 - 47
  • [38] HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B
    Sonneveld, Milan J.
    Rijckborst, Vincent
    Zoutendijk, Roeland
    Gerken, Guido
    Tabak, Fehmi
    Mach, Tomasz H.
    Boucher, Charles A.
    Hansen, Bettina E.
    Janssen, Harry L.
    HEPATOLOGY, 2011, 54 : 1030A - 1030A
  • [39] Addition of PEG-interferon to long-term nucleos(t)ide analogue therapy enhances HBsAg decline and clearance in HBeAg-negative chronic hepatitis B: Multicentre Randomized Trial (PAS Study)
    Farag, Mina S.
    van Campenhout, Margo J. H.
    Sonneveld, M. J.
    Fung, Scott
    van Erpecum, Karel J.
    Wong, David K.
    Verhey, Elke
    de Man, Robert
    De Knegt, Robert J.
    Brouwer, Johannes T.
    Baak, Hubertus C.
    Feld, Jordan J.
    Liem, Kin Seng
    Boonstra, Andre
    Hansen, Bettina E.
    Janssen, Harry L. A.
    JOURNAL OF VIRAL HEPATITIS, 2024, 31 (04) : 197 - 207
  • [40] The efficacy and safety of adding on or switching to peginterferon α-2b in HBeAg-positive chronic hepatitis B patients with long-term entecavir treatment: A multicentre randomised controlled trial
    Hu, Qiankun
    Qi, Xun
    Yu, Yiqi
    Gao, Yueqiu
    Zhang, Xinxin
    Wang, Qianqian
    Zhang, Xueyun
    Zhuo, Yunhui
    Li, Jing
    Zhang, Jiming
    Chen, Liang
    Huang, Yuxian
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (09) : 1394 - 1407
12345